NRG
Nemes Rush Group Portfolio holdings
AUM
$917M
1-Year Return
21.87%
This Quarter Return
+13.93%
1 Year Return
+21.87%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$697M
AUM Growth
+$77.6M
(+13%)
Cap. Flow
+$6.97M
Cap. Flow
% of AUM
1%
Top 10 Holdings %
Top 10 Hldgs %
33.71%
Holding
709
New
50
Increased
151
Reduced
133
Closed
44
Top Buys
| 1 |
Novo Nordisk
NVO
|
$12M |
| 2 |
Eli Lilly
LLY
|
$8.12M |
| 3 |
Union Pacific
UNP
|
$4.3M |
| 4 |
Merck
MRK
|
$1.68M |
| 5 |
Best Buy
BBY
|
$1.52M |
Top Sells
| 1 |
Medtronic
MDT
|
$10.2M |
| 2 |
Edwards Lifesciences
EW
|
$4.39M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$4.24M |
| 4 |
iShares US Transportation ETF
IYT
|
$4.05M |
| 5 |
NVIDIA
NVDA
|
$2.67M |
Sector Composition
| 1 | Technology | 31.77% |
| 2 | Financials | 14.79% |
| 3 | Healthcare | 11.63% |
| 4 | Industrials | 11.45% |
| 5 | Consumer Discretionary | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Procter & Gamble
PG
$373B
| $1.35M | 0.19% |
8,293
-111
| -1% | -$18K |
|
77
Carlisle Companies
CSL
$16.8B
| $1.25M | 0.18% |
3,200
| – | – |
|
78
Chevron
CVX
$318B
| $1.25M | 0.18% |
7,897
-233
| -3% | -$36.8K |
|
79
Airbnb
ABNB
$76.8B
| $1.19M | 0.17% |
7,217
-97
| -1% | -$16K |
|
80
Cigna
CI
$81.2B
| $1.18M | 0.17% |
3,246
-40
| -1% | -$14.5K |
|
81
Adobe
ADBE
$146B
| $1.15M | 0.17% |
2,286
+68
| +3% | +$34.3K |
|
|
82
Medtronic
MDT
$119B
| $1.15M | 0.16% |
13,139
-116,862
| -90% | -$10.2M |
|
83
Diamondback Energy
FANG
$41.3B
| $1.12M | 0.16% |
5,674
-65
| -1% | -$12.9K |
|
84
McDonald's
MCD
$226B
| $1.12M | 0.16% |
3,969
-70
| -2% | -$19.7K |
|
85
Tractor Supply
TSCO
$32.1B
| $1.05M | 0.15% |
20,025
+2,895
| +17% | +$152K |
|
86
Technology Select Sector SPDR Fund
XLK
$84B
| $1.05M | 0.15% |
5,030
+143
| +3% | +$29.8K |
|
87
lululemon athletica
LULU
$24.7B
| $1.02M | 0.15% |
2,620
-25
| -0.9% | -$9.77K |
|
88
Target
TGT
$42.1B
| $979K | 0.14% |
5,523
-477
| -8% | -$84.5K |
|
89
Vanguard Mid-Cap Growth ETF
VOT
$17.6B
| $933K | 0.13% |
3,958
| – | – |
|
90
SPDR S&P MidCap 400 ETF Trust
MDY
$23.9B
| $933K | 0.13% |
1,677
+28
| +2% | +$15.6K |
|
91
Vanguard Small-Cap Growth ETF
VBK
$20.2B
| $913K | 0.13% |
3,501
| – | – |
|
|
92
Edwards Lifesciences
EW
$47.5B
| $890K | 0.13% |
9,318
-45,919
| -83% | -$4.39M |
|
93
Nucor
NUE
$33.3B
| $878K | 0.13% |
4,437
-82
| -2% | -$16.2K |
|
94
iShares Core S&P Mid-Cap ETF
IJH
$101B
| $860K | 0.12% |
14,155
+880
| +7% | +$53.5K |
|
95
Vanguard Small-Cap Value ETF
VBR
$31.6B
| $833K | 0.12% |
4,342
+63
| +1% | +$12.1K |
|
96
Prudential Financial
PRU
$38.3B
| $830K | 0.12% |
7,074
+35
| +0.5% | +$4.11K |
|
97
Moderna
MRNA
$9.45B
| $825K | 0.12% |
7,745
+2,308
| +42% | +$246K |
|
98
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.12B
| $800K | 0.11% |
6,765
| – | – |
|
99
PepsiCo
PEP
$201B
| $778K | 0.11% |
4,443
-157
| -3% | -$27.5K |
|
100
AbbVie
ABBV
$376B
| $762K | 0.11% |
4,186
-96
| -2% | -$17.5K |
|